Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities
Net income	$ 80,855	$ 22,050	$ 35,663
Adjustments to reconcile net income to net cash provided by operating activities:
Net (discount accretion) premium amortization	(23,391)	(12,523)	2,040
Depreciation and amortization expense	15,271	9,690	4,340
Provision for credit losses - loans	126	17,408	1,682
Recovery of credit losses - unfunded loan commitments	(100)	(862)	0
Share-based compensation	5,013	8,719	2,356
Gains on sales of loans originated for sale	(1,287)	(810)	(283)
Fair value adjustment on loans held for sale	3	(131)	323
Mortgage loans originated for sale	(58,611)	(43,928)	(18,437)
Proceeds from sales of loans originated for sale	60,419	44,071	23,461
Net gain on disposal of OREO and premises held for sale	(119)	0	(436)
Net loss on disposal of premises and equipment	19	381	252
Deferred income tax (benefit)	5,999	(867)	(651)
Investment securities (gains) losses	(166)	(249)	47
Provision for legal settlement	0	478	0
Net losses (gains) on derivatives	272	(276)	373
Income from life insurance	(5,402)	(3,866)	(2,482)
Premium on branch sale	0	0	(1,102)
Decrease (increase) in accrued interest receivable and other assets	5,429	(10,610)	1,571
(Decrease) increase in accrued interest payable and other liabilities	(10,805)	4,165	(5,651)
Other, net	1,209	2,119	635
Net cash provided by operating activities	74,734	34,959	43,701
Cash flows from investing activities
Proceeds from sales of AFS securities	83,876	162,669	22,006
Maturities, repayments and calls of AFS securities	85,213	76,054	34,989
Purchases of AFS securities	(272,279)	(227,979)	(45,565)
Net cash and cash equivalents received from acquisitions	0	45,280	0
Net purchases of restricted investments in bank stocks	(6,485)	(7,072)	(1,350)
Net (increase) decrease in loans	(69,561)	19,725	(145,301)
Proceeds from sales of portfolio loans	0	7,036	0
Investment in limited partnerships, net	(1,538)	(7,764)	(871)
Purchases of bank premises and equipment	(4,235)	(1,582)	(2,293)
Proceeds from disposal of OREO and premises held for sale	2,182	0	2,536
Proceeds from disposal of bank premises and equipment	18	0	43
Net cash paid in branch sale	0	0	(17,641)
Purchases of bank owned life insurance	0	(5,000)	0
Death benefit proceeds from life insurance contracts	864	0	342
Other	(15)	(374)	(143)
Net cash (used in) provided by investing activities	(181,960)	60,993	(153,248)
Cash flows from financing activities
Net (decrease) increase in deposits	(95,260)	116,884	101,302
Net decrease (increase) in borrowings with original maturities less than 90 days	38,079	(14,365)	(14,650)
Proceeds from FHLB advances with original maturities greater than 90 days	135,000	0	40,000
Payments on FHLB advances with original maturities greater than 90 days	(15,000)	0	(1,455)
Payments on subordinated notes	(32,500)	0	0
Dividends paid	(20,643)	(13,177)	(8,485)
Acquisition of treasury stock	(263)	0	(2,585)
Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting	(2,009)	(2,393)	(378)
Proceeds from issuance of employee stock purchase plan shares	151	267	136
Other	571	545	0
Net cash provided by financing activities	8,126	87,761	113,885
Net (decrease) increase in cash and cash equivalents	(99,100)	183,713	4,338
Cash and cash equivalents at beginning of year	248,874	65,161	60,823
Cash and cash equivalents at end of year	149,774	248,874	65,161
Supplemental disclosure of cash flow information:
Interest	103,369	93,315	42,888
Income taxes	9,100	9,625	7,450
Supplemental schedule of noncash investing and financing activities:
OREO acquired in settlement of loans	0	0	85
Premises and equipment transferred to held for sale	0	1,925	0
Lease liabilities arising from obtaining ROU assets	2,008	0	2,416
Noncash transactions related to merger:
Assets acquired	0	2,156,831	0
Liabilities assumed	$ 0	$ 2,018,067	$ 0